<DOC>
	<DOCNO>NCT01070979</DOCNO>
	<brief_summary>Multicenter , double-blind , control , parallel group , randomize study compare clinical benefit Estradiol acetate tablet , estradiol tablet conjugate equine estrogen tablet , administer orally , daily , postmenopausal woman .</brief_summary>
	<brief_title>Hormone Replacement Therapy Use Postmenopausal Women Relief Hot Flushes Urogenital Symptoms .</brief_title>
	<detailed_description />
	<mesh_term>Estrogens , Conjugated ( USP )</mesh_term>
	<mesh_term>Estradiol</mesh_term>
	<mesh_term>Polyestradiol phosphate</mesh_term>
	<mesh_term>Estrogens</mesh_term>
	<mesh_term>Estradiol 3-benzoate</mesh_term>
	<mesh_term>Estradiol 17 beta-cypionate</mesh_term>
	<mesh_term>Estradiol valerate</mesh_term>
	<criteria>1 . Age ≥ 40 year age ; bilateral oophorectomy ≥ 35 year age . 2 . Nonhysterectomized woman : Amenorrhea ≥ 12 month Amenorrhea ≤ 12 month , longer 6 month , serum FSH ( follicle stimulate hormone ) level &gt; 40 units/L serum estradiol level &lt; 20 pg /mL , Hysterectomized woman : Bilateral oophorectomy subject may enter study 6 week surgery History removal ovary may confirm serum FSH level &gt; 40 units/L serum estradiol level &lt; 20 pg/mL via surgical report / ultrasound . 3 . Seven moderate severe hot flush daily 1 week 60 moderate severe flush 1 week 2 week screening period prior study entry . 1 . Hormone therapy administer via follow route specify timeframes : oral within 8 week , vaginal ( ring , cream , gel ) within 1 week , transdermal within 4 week , intramuscular within 6 week , progestational implant , estrogen estrogen/progestational injectable drug therapy within 3 month , estrogen pellet progestational injectable within 6 month . 2 . Abnormal Pap smear suggestive low grade squamous intraepithelial lesion ( LGSIL ) bad . Enrollment subject ASCUS ( atypical squamous cell undetermined significance ) interpretation must discuss sponsor prior randomization . 3 . Urinary tract infection 4 . Congestive heart failure 5 . Uncontrolled hypertension ; sit systolic BP ≥ 160 mmHg diastolic ≥ 95 mmHg 6 . History stroke transient ischemic attack 7 . Treatment anticoagulant ( heparin warfarin ) . 8 . Uncontrolled thyroid disorder . 9 . Insulindependent diabetes mellitus . 10 . Increase frequency severity headache include migraine previous estrogen therapy .</criteria>
	<gender>Female</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2013</verification_date>
</DOC>